SISB INVESTMENT ADVISERS (UK) LTD
Institutional investor · Portfolio as of Q1 2020
Top Holdings5 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
UBER TECHNOLOGIES INC | 222.2M | $6.2B | 66.8% | $46.38 | -40.00% | 4 qtrssince 2019-Q2 | Unchanged 0 |
Guardant Health, Inc. | 23M | $1.6B | 17.2% | $40.56 | +75.68% | 6 qtrssince 2018-Q4 | Unchanged 0 |
VIR BIOTECHNOLOGY INC | 22.6M | $775.1M | 8.4% | $12.12 | +192.90% | 2 qtrssince 2019-Q4 | Unchanged 0 |
SLACK TECHNOLOGIES INC | 17.4M | $466M | 5.0% | — | — | 3 qtrssince 2019-Q3 | Decreased 0 |
10x Genomics Inc Class A | 3.8M | $239.1M | 2.6% | $62.80 | 0.00% | 1 qtr | New 82 |
SB INVESTMENT ADVISERS (UK) LTD manages $9.3B across 5 positions as of Q1 2020. Top holdings: UBER (66.8%), GH (17.2%), VIR (8.4%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 2/5.0.
Added 1 new position, exited 1, trimmed 1. Top move: TXG (NEW, conviction 82). Portfolio: $9.3B across 5 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer